Organization | Loma Linda University

Loma Linda University Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Loma Linda CA United States (1905)

Organization Overview

First Clinical Trial

1999

NCT00614484

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

Abel Torres, MD | Ardmore Institute of Health | Attending Nephrologist, Loma Linda University Medical Center | Cardiac Arrhythmia Service, Loma Linda University Health, Loma Linda, CA | Center for Dental Research, Loma Linda University School of Dentistry | Charles Lee MD | Department of Physical Therapy School of Allied Health Professions, Loma Linda University | Faculty Physicains & Surgeons of Loma Linda University School of Medicine, Department of Neurology | Glendale Adventist Medical Center, Glendale, California | Loma Linda Department of Otolaryngology | Loma Linda Univeristy | Loma Linda University | Loma Linda University Adventist Health Sciences Center | Loma Linda University Cancer Center | Loma Linda University Department of Ophthalmology | Loma Linda University Department of Orthopaedics | Loma Linda University Department of Orthopedics | Loma Linda University Department of Pediatric Dentistry | Loma Linda University Department of Radiation Medicine | Loma Linda University Department of Vascular Surgery | Loma Linda University Health | Loma Linda University Health System | Loma Linda University, Loma Linda, California, USA | Loma Linda University Medical Center | Loma Linda University O&P | Loma Linda University Otolaryngology Department | Loma Linda University, School of Allied Health Professions | Loma Linda University School of Dentistry | Loma Linda University School of Dentistry, Center for Dental Research | Loma Linda University, Urology Medical Group, Inc. | Michelle Schlunt MD | Sheela Patel | Warren Peters, MD, MPH

Active Ingredients

Drugs in Phase 4 Trials (18)

acetylsalicylic acid (aspirin) (1 trial)

bupivacaine (Exparel) (3 trials)

cetylpyridinium chloride (1 trial)

cyclosporine (sandimmune) (1 trial)

ergocalciferol (drisdol) (1 trial)

gabapentin (neurontin) (2 trials)

hydrogen peroxide (3 trials)

levobupivacaine (chirocaine) (2 trials)

magnesium sulfate (Tis-U-Sol) (2 trials)

milnacipran (savella) (1 trial)

omeprazole (prilosec) (1 trial)

pantoprazole (protonix) (1 trial)

prednisone (meticorten) (3 trials)

ranitidine (zantac) (1 trial)

sodium fluoride (18F) (2 trials)

tacrolimus (prograf) (1 trial)

tin difluoride (1 trial)

triclosan (1 trial)

Drugs in Phase 3 Trials (14)

acetaminophen (tylenol) (6 trials)

ashwagandha extract (1 trial)

cytisine (1 trial)

dalfampridine (ampyra) (1 trial)

dexamethasone (1 trial)

diclofenac (voltaren) (1 trial)

hydrocodone (hycodan) (4 trials)

hypochlorous acid (1 trial)

ibuprofen (motrin) (2 trials)

midazolam (versed) (1 trial)

nicotine (nicorette) (1 trial)

petrolatum, white (Vaseline) (1 trial)

semaglutide (Ozempic) (1 trial)

zolpidem (ambien) (1 trial)

Drugs in Phase 2 Trials (18)

aldesleukin (Proleukin) (1 trial)

capecitabine (xeloda) (1 trial)

carboplatin (paraplatin) (2 trials)

curcumin (2 trials)

droxidopa (northera) (1 trial)

erlotinib (tarceva) (1 trial)

Fluciclovine (Axumin) (1 trial)

furosemide (lasix) (1 trial)

gemcitabine (gemzar) (2 trials)

lidocaine (xylocaine) (5 trials)

nitric oxide (inomax) (1 trial)

paclitaxel (taxol) (2 trials)

pomegranate (1 trial)

s-adenosyl methionine (1 trial)

sildenafil (viagra) (1 trial)

sodium chloride (4 trials)

tazemetostat (Tazverik) (1 trial)

vismodegib (erivedge) (1 trial)

Drugs in Phase 1 Trials (14)

azacitidine (vidaza) (1 trial)

bosentan (tracleer) (1 trial)

botulism antitoxin bivalent (equine) types a and b (1 trial)

botulism antitoxin heptavalent (a, b, c, d, e, f, g) - (equine) (BAT) (1 trial)

ciprofloxacin (cipro) (2 trials)

cisplatin (platinol) (1 trial)

docetaxel (taxotere) (1 trial)

elenbecestat (1 trial)

iloprost (ventavis) (1 trial)

metronidazole (flagyl) (1 trial)

minocycline (minocin) (1 trial)

oxaliplatin (eloxatin) (1 trial)

parabens (1 trial)

pegylated arginine deiminase (1 trial)

Drugs in Other Trials (51)

almond (1 trial)

amino acids (Freamine) (1 trial)

aminocaproic acid (amicar) (1 trial)

avocado (1 trial)

bacillus coagulans (1 trial)

beetroot juice (1 trial)

blueberry (1 trial)

bone mineral matrix (1 trial)

caffeine (1 trial)

cellulose (1 trial)

clavulanate (Augmentin) (1 trial)

collagen (1 trial)

dark chocolate (2 trials)

diazepam (valium) (1 trial)

epinephrine (levophed) (2 trials)

esmolol (brevibloc) (1 trial)

fentanyl (Innovar) (1 trial)

ferric sulfate (1 trial)

galactomannans (1 trial)

ginger (2 trials)

glucose (2 trials)

immune globulin (human) (Gamastan) (1 trial)

labetalol (trandate) (1 trial)

macadamia (1 trial)

melatonin (1 trial)

mineral trioxide (1 trial)

morphine (3 trials)

nifedipine (procardia) (1 trial)

nitroglycerin (transderm-nitro) (1 trial)

oxycodone (oxycontin) (1 trial)

peanut (2 trials)

piperacillin (pipracil) (1 trial)

platelet-rich plasma (2 trials)

pregabalin (lyrica) (1 trial)

prilocaine (citanest) (1 trial)

propofol (diprivan) (1 trial)

resveratrol (1 trial)

rimabotulinumtoxinB (Myobloc) (1 trial)

ringer's lactate (1 trial)

ropivacaine (naropin) (3 trials)

sevelamer (renagel) (1 trial)

sorafenib (nexavar) (1 trial)

soybean (3 trials)

sucrose (1 trial)

surfactant (1 trial)

tazobactam (Zosyn) (1 trial)

thiamine (1 trial)

tranexamic acid (cyklokapron) (1 trial)

walnut (3 trials)

zonisamide (Zonegran) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Adenocarcinoma (Phase 2)

Alzheimer Disease (Phase 1)

Anxiety Disorders (Phase 3)

Asthma (Phase 2)

Atrophy (Phase 2)

Behavior, Addictive (Phase 3)

Botulism (Phase 1)

Brain Neoplasms (Phase 2)

Calcinosis (Phase 4)

Carcinoma (Phase 2)

Carcinoma, Basal Cell (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 1)

Carcinoma, Ovarian Epithelial (Phase 1)

Carcinoma, Renal Cell (Phase 2)

Carcinoma, Squamous Cell (Phase 1)

Cataract (Phase 3)

Chronic Periodontitis (Phase 4)

Delayed Graft Function (Phase 2)

Dental Plaque (Phase 4)

Dental Pulp Necrosis (Phase 1)

Dyskinesias (Phase 2)

Dyssomnias (Phase 3)

Emergencies (Phase 1)

Endophthalmitis (Phase 3)

Fatigue (Phase 4)

Fibromyalgia (Phase 4)

Fractures, Stress (Phase 3)

Gastroesophageal Reflux (Phase 4)

Gingivitis (Phase 4)

Hepatitis, Alcoholic (Phase 2)

Hypersensitivity (Phase 3)

Hypertension, Pulmonary (Phase 1)

Hypoxia (Phase 1)

Kidney Neoplasms (Phase 2)

Laryngopharyngeal Reflux (Phase 4)

Leg Ulcer (Phase 2)

Liver Diseases (Phase 2)

Liver Diseases, Alcoholic (Phase 2)

Lung Neoplasms (Phase 2)

Lupus Erythematosus, Systemic (Phase 4)

Melanoma (Phase 2)

Multiple Sclerosis (Phase 3)

Multiple System Atrophy (Phase 2)

Musculoskeletal Pain (Phase 1)

Myofascial Pain Syndromes (Phase 4)

Nasal Polyps (Phase 4)

Necrosis (Phase 1)

Osteoarthritis, Knee (Phase 1)

Ovarian Neoplasms (Phase 1)

Pain, Postoperative (Phase 4)

Pancreatic Neoplasms (Phase 2)

Paralysis (Phase 1)

Parasomnias (Phase 3)

Parkinson Disease (Phase 2)

Parkinsonian Disorders (Phase 2)

Periodontitis (Phase 4)

Polyps (Phase 4)

Sclerosis (Phase 3)

Shy-Drager Syndrome (Phase 2)

Sinusitis (Phase 4)

Sleep Wake Disorders (Phase 3)

Squamous Cell Carcinoma of Head and Neck (Phase 1)

Stroke (Phase 2)

Supranuclear Palsy, Progressive (Phase 2)

Ulcer (Phase 2)

Urologic Diseases (Phase 4)

Weight Loss (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 107
# of Trial APIs: 115